Drug Delivery Platforms (like Flow Pharma) and companies developing devices for treating neurological and psychiatric conditions (like PhotoThera) emerged as large upcoming areas in the Medical Devices (by Specialty) sector.
The year so far saw $5.8B invested across 410 rounds. While both these figures dimmed in comparison to 2016, the avg ticket size per round went up by 66% from 2016. Average ticket sizes for $1.1M (Seed stage), $6.5M (Series A), and $15.7M (Series B). As for the total funding in 2017, it was $66M for the Seed Stage, $1.42B for the Early Stage (till Series B), and $3.6B for the late stage rounds.
Some notable latest investments in the sector are Verily ($800M, PE Round), Intarcia ($525M, Series J) and Auris Surgical Robotics ($280M, Series D). Western Technology Investment emerged as the leading investor in the space, with 64 investments. Top investors by stage are High-Tech Grunderfonds for Seed Stage (22 investments), New Enterprise Assocites for Series A and B (18 and 23 investments respectively), and JJDC for Later Stage (30 investments)
Note: You can download the full-version of this report here.